Pharma and Biotech Research News New York

Pharma, Biopharma & Biotech News

KKR is acquiring rare disease platform Immedica Pharma and partnering with Impilo

KKR and Impilo will work together with Immedica’s management team to support Immedica’s continued growth

Kryptos Biotechnologies raises $10 million for clinical studies for its point-of-care molecular diagnostics system

Point-of-care testing requires comprehensive requirements in accuracy, speed, cost, and usability

Clinical-stage oncology company, Boundless Bio prices initial public offering to raise $100 million

Boundless Bio is interrogating extrachromosomal DNA biology to deliver transformative therapies to patients

IGC Pharma closes $3 Million private placement to advance Alzheimer's treatment

IGC Pharma Inc. (“IGC”) is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness.

WebMD partners with Onduo, a business unit of Alphabet's Verily, to enhance employee health and well-being

This partnership addresses members' needs by combining cutting-edge technology with comprehensive health and well-being solutions.

VitalPoint Technologies to acquire an alternative medicine platform with tech-driven solutions to combat the opioid and mental health crisis

As a bio-pharmaceutical company, we are at the forefront of leveraging technology to provide non-opioid alternatives to hospice patients.

Kenai Therapeutics closes $82 Million to advance next generation allogeneic cell therapies for neurological diseases, including Parkinson's

The Company utilizes allogeneic induced pluripotent stem cell (iPSC) technology, a Nobel Prize-winning breakthrough

Healthcare technology company Aclarion (Nasdaq: ACON), with a focus on lower back pain, raises $3 million in a public offering

addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicans

enGene raises $200 Million to advance a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer

enGene is a biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs.